For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshiaki Sai, General Manager,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/

Notice of Delay in Some Shipments of Kitasato Daiichi Sankyo Flu Vaccine

Tokyo, Japan (September12, 2011) – Daiichi Sankyo Company Limited (hereafter, Daiichi Sankyo) today announced that some batches of its Kitasato Daiichi Sankyo influenza HA vaccine and Kitasato Daiichi Sankyo influenza HA vaccine syringe produced by its subsidiary, Kitasato Daiichi Sankyo Vaccine, did not meet criteria in a test of quality standards.

 

Consequently, some shipments of the two products scheduled within this month will be delayed. Daiichi Sankyo offers its deepest apologies to all healthcare professionals and other persons who are waiting for this vaccine.

 

Another announcement will be made about the supply of these products at a later date.